Iwona Homa‐Mlak

413 total citations
37 papers, 289 citations indexed

About

Iwona Homa‐Mlak is a scholar working on Physiology, Molecular Biology and Otorhinolaryngology. According to data from OpenAlex, Iwona Homa‐Mlak has authored 37 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 11 papers in Molecular Biology and 10 papers in Otorhinolaryngology. Recurrent topics in Iwona Homa‐Mlak's work include Head and Neck Cancer Studies (10 papers), Multiple Myeloma Research and Treatments (9 papers) and Nutrition and Health in Aging (8 papers). Iwona Homa‐Mlak is often cited by papers focused on Head and Neck Cancer Studies (10 papers), Multiple Myeloma Research and Treatments (9 papers) and Nutrition and Health in Aging (8 papers). Iwona Homa‐Mlak collaborates with scholars based in Poland, United States and Ireland. Iwona Homa‐Mlak's co-authors include Teresa Małecka‐Massalska, Radosław Mlak, Anna Brzozowska, Tomasz Powrózek, Michał Mielnik, Agata Michalak, Marek Hus, Halina Cichoż‐Lach, Marzanna Ciesielka and Michał Szczyrek and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and British Journal of Haematology.

In The Last Decade

Iwona Homa‐Mlak

33 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iwona Homa‐Mlak Poland 12 75 72 69 64 63 37 289
Francisco G. Pernas United States 8 40 0.5× 81 1.1× 42 0.6× 121 1.9× 11 0.2× 8 404
Giovanni William Oliverio Italy 13 59 0.8× 111 1.5× 24 0.3× 59 0.9× 9 0.1× 41 525
Yue Du China 7 93 1.2× 24 0.3× 41 0.6× 58 0.9× 26 0.4× 44 263
Marcos Venício Alves Lima Brazil 9 34 0.5× 131 1.8× 26 0.4× 29 0.5× 13 0.2× 31 330
Mohammad Shirkhoda Iran 10 45 0.6× 79 1.1× 22 0.3× 100 1.6× 19 0.3× 54 311
Archana Deshpande India 12 27 0.4× 108 1.5× 32 0.5× 22 0.3× 14 0.2× 43 308
R. J. Sanderson United Kingdom 8 104 1.4× 110 1.5× 52 0.8× 75 1.2× 8 0.1× 14 374
Bikramjit Singh India 7 27 0.4× 54 0.8× 9 0.1× 29 0.5× 24 0.4× 20 266
T. K. Padmanabhan India 11 50 0.7× 116 1.6× 18 0.3× 22 0.3× 71 1.1× 22 363
Benoît Roch France 11 116 1.5× 158 2.2× 79 1.1× 164 2.6× 126 2.0× 32 493

Countries citing papers authored by Iwona Homa‐Mlak

Since Specialization
Citations

This map shows the geographic impact of Iwona Homa‐Mlak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iwona Homa‐Mlak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iwona Homa‐Mlak more than expected).

Fields of papers citing papers by Iwona Homa‐Mlak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iwona Homa‐Mlak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iwona Homa‐Mlak. The network helps show where Iwona Homa‐Mlak may publish in the future.

Co-authorship network of co-authors of Iwona Homa‐Mlak

This figure shows the co-authorship network connecting the top 25 collaborators of Iwona Homa‐Mlak. A scholar is included among the top collaborators of Iwona Homa‐Mlak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iwona Homa‐Mlak. Iwona Homa‐Mlak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Homa‐Mlak, Iwona, et al.. (2025). Quantification of Citrullinated Histone H3 as a Marker for Neutrophil Extracellular Traps Correlated to Clinical Characteristics of Patients with Systemic Lupus Erythematosus. Archivum Immunologiae et Therapiae Experimentalis. 73(1). 1 indexed citations
2.
Homa‐Mlak, Iwona, et al.. (2024). An Emerging Role of Long Noncoding RNAs as Novel Biomarkers for Breast Cancer Metastasis. Applied Sciences. 14(15). 6667–6667.
5.
Mlak, Radosław, et al.. (2024). Role of Non-Coding RNAs in Diagnosis, Prediction and Prognosis of Multiple Myeloma. Cancers. 16(5). 1033–1033. 3 indexed citations
7.
Mlak, Radosław, Sylwia Chocholska, Michał Szczyrek, et al.. (2023). The TT Genotype of the KIAA1524 rs2278911 Polymorphism Is Associated with Poor Prognosis in Multiple Myeloma. Cells. 12(7). 1029–1029. 1 indexed citations
8.
Mielnik, Michał, et al.. (2023). The Clinical Relevance of Selected Cytokines in Newly Diagnosed Multiple Myeloma Patients. Biomedicines. 11(11). 3012–3012. 5 indexed citations
9.
Mlak, Radosław, Michał Mielnik, Sylwia Chocholska, et al.. (2022). Circulating Serum MiRNA-8074 as a Novel Prognostic Biomarker for Multiple Myeloma. Cells. 11(4). 752–752. 5 indexed citations
10.
Homa‐Mlak, Iwona, et al.. (2021). Neutrophil-to-Lymphocyte Ratio as a Factor Predicting Radiotherapy Induced Oral Mucositis in Head Neck Cancer Patients Treated with Radiotherapy. Journal of Clinical Medicine. 10(19). 4444–4444. 15 indexed citations
11.
Bojar, Iwona, et al.. (2021). Association between myostatin serum concentration and body fat level in peri- and postmenopausal women.. Archives of Medical Science. 18(2). 365–375. 2 indexed citations
12.
Mlak, Radosław, Michał Mielnik, Michał Szczyrek, et al.. (2020). Prognostic value of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in multiple myeloma patients treated with thalidomide-based regimen. Annals of Hematology. 99(12). 2881–2891. 16 indexed citations
13.
Mlak, Radosław, Michał Mielnik, Iwona Homa‐Mlak, et al.. (2020). Serum brain‐derived neurotrophic factor (BDNF) concentration predicts polyneuropathy and overall survival in multiple myeloma patients. British Journal of Haematology. 191(1). 77–89. 18 indexed citations
15.
Mlak, Radosław, Michał Szczyrek, Iwona Homa‐Mlak, et al.. (2019). Polymorphisms in the promotor region of the CRBN gene as a predictive factor for peripheral neuropathy in the course of thalidomide‐based chemotherapy in multiple myeloma patients. British Journal of Haematology. 186(5). 695–705. 7 indexed citations
17.
Mlak, Radosław, Paweł Krawczyk, Iwona Homa‐Mlak, et al.. (2018). Predictive Value of Single Nucleotide Polymorphisms of ERCC1, XPA, XPC, XPD and XPG Genes, Involved in NER Mechanism in Patients with Advanced NSCLC Treated with Cisplatin and Gemcitabine. Pathology & Oncology Research. 25(3). 1035–1045. 6 indexed citations
18.
Brzozowska, Anna, Tomasz Powrózek, Iwona Homa‐Mlak, et al.. (2017). Polymorphism of Promoter Region of TNFRSF1A Gene (−610 T > G) as a Novel Predictive Factor for Radiotherapy Induced Oral Mucositis in HNC Patients. Pathology & Oncology Research. 24(1). 135–143. 18 indexed citations
19.
Małecka‐Massalska, Teresa, et al.. (2017). Application of phase angle for evaluation of the nutrition status of patients with anorexia nervosa. Psychiatria Polska. 51(6). 1121–1131. 21 indexed citations
20.
Homa‐Mlak, Iwona, et al.. (2016). Metastatic potential of NET in neoplastic disease. Postępy Higieny i Medycyny Doświadczalnej. 70(0). 887–895. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026